Isotope Chemistry

Almac has extensive experience in the synthesis and analysis of stable and 14C isotope labelled compounds.  We can label almost any compound at any stage between drug discovery and launch – including small molecules, peptides, cytotoxics and conjugates.

Working from dedicated state of the art facilities, Almac provides a complete suite of solutions for your radiolabelling needs including:

  • Synthesis Route Design
  • cGMP Supply of API (Drug Substance) and IMP (Investigational Medicinal Product) (Drug Product) for Preclinical ADME Studies
  • QC and Analytical Support Including Method Development and Validation, Method Transfer and Stability Studies
  • Storage and Repurification

Certified with a 14C IMP license and MHRA cGMP compliance certificate, Almac is fully equipped to deliver an industry leading radiolabelling service which is high in quality, cost effective and true to your deadlines.

Almac Advantage

Experience

Over 15 years experience in the synthesis and analysis of stable isotope labelled compounds

Facilities

Dedicated, state of the art API and IMP facilities

Quality

MHRA accreditation for cGMP manufacture and IMP drug product manufacturing license

Flash replacement image